Heat helps cancer drugs battle cancer

May 10, 2011 by Deborah Braconnier in Cancer report

(PhysOrg.com) -- Localized hyperthermia has been used occasionally with cancer drugs for some time, but until now, the reason it helps has been a mystery. In a report in the Proceedings of the National Academy of Sciences, scientists have discovered that the addition of heat inhibits homologous recombination so the cancer cells are unable to repair DNA damage caused by the cancer treatments.

Originally used in the 70s and 80s, hyperthermia showed promise in inhibiting the repair mechanism, though clinical trials at the time were unable to establish a definitive connection and interest in the combination diminished. However, new technology and clinical trials have brought it back into the spotlight, and this new study may just give it the fuel it needs.

Przemek Krawczyk from the University of Amsterdam and his team studied tumor cells both in a and those injected into rats. They discovered that when the cells were heated to 106-109 degrees Fahrenheit, the protein BRCA2 (essential for repair pathway) was degraded and thus blocked homologous recombination.

This new finding opens up the possibility for a new type of drug, called PARP, to have a wider range of possible cancer treating options. PARP is currently under clinical trials to treat a certain type of hereditary breast cancer. In this particular cancer, BRCA1 is mutated and already unable to repair . PARP is specifically designed to attack these already mutated tumor cells.

If hyperthermia is able to cause the same type of defect in , the door could be opened for PARP to be used to treat many other cancers. PARP has shown to be well tolerated by many patients with very few side effects compared to current chemotherapy treatments.

More information: Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition, PNAS, Published online before print May 9, 2011, doi: 10.1073/pnas.1101053108

Abstract
Defective homologous recombination (HR) DNA repair imposed by BRCA1 or BRCA2 deficiency sensitizes cells to poly (ADP-ribose) polymerase (PARP)-1 inhibition and is currently exploited in clinical treatment of HR-deficient tumors. Here we show that mild hyperthermia (41–42.5 °C) induces degradation of BRCA2 and inhibits HR. We demonstrate that hyperthermia can be used to sensitize innately HR-proficient tumor cells to PARP-1 inhibitors and that this effect can be enhanced by heat shock protein inhibition. Our results, obtained from cell lines and in vivo tumor models, enable the design of unique therapeutic strategies involving localized on-demand induction of HR deficiency, an approach that we term induced synthetic lethality.

© 2010 PhysOrg.com

5 /5 (4 votes)  

Rank 5 /5 (4 votes)
Relevant PhysicsForums posts
  • Poor nutrition leading to overeating?
    created4 hours ago
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • A couple of questions about schizophrenia
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Breast MRI helps predict chemotherapy's effectiveness

Magnetic resonance imaging (MRI) provides an indication of a breast tumor's response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online ...

Cancer created 40 minutes ago | popularity not rated yet | comments 0

Colonoscopy may detect curable cancer in elderly: study

(HealthDay) -- Colonoscopies helped doctors detect a high rate of curable cancer in elderly people who had the screening for the first time, a new study indicates.

Cancer created 10 hours ago | popularity 5 / 5 (2) | comments 0

Scientists see potential in novel leukemia treatment

Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill ...

Cancer created 11 hours ago | popularity 5 / 5 (1) | comments 0

Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy

Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part ...

Cancer created 11 hours ago | popularity not rated yet | comments 0

Scientists unravel role of fusion gene in prostate cancer

Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein -- but no one has known how that alteration promotes cancer growth. Now, Weill ...

Cancer created 13 hours ago | popularity 5 / 5 (3) | comments 0 | with audio podcast


Scientists start explaining Fat Bastard's vicious cycle

Fat Bastard's revelation "I eat because I'm depressed and I'm depressed because I eat" in the Austin Powers film series may be explained by sophisticated neuroscience research being undertaken by scientists affiliated with ...

Socioeconomics may affect toddlers' exposure to flame retardants

A Duke University-led study of North Carolina toddlers suggests that exposure to potentially toxic flame-retardant chemicals may be higher in nonwhite toddlers than in white toddlers.

Kids suffer long-term from parents' smoking: study

Children exposed to their parents' cigarette smoke are at greater risk of suffering serious cardiovascular health problems later in life, a study showed Wednesday.

Hair loss pathology identified in pityriasis versicolor lesions

(HealthDay) -- Patients with pityriasis versicolor (PV) lesions may experience hair thinning and/or loss within the lesion, according to a study published online May 10 in the Journal of the American Academy of ...

New study confirms value of cardiac output monitor

(Medical Xpress) -- A new Australian study has confirmed the accuracy of a modern non-invasive cardiac output monitor that can replace a 40-year-old standard in this field.

South Korean smokers finally start to feel the heat

After decades of indifference, big businesses and the government are turning up the heat on smokers in South Korea, a nation with one of the developed world's highest male smoking rates.